P-21 activated kinase 1 knockdown inhibits β-catenin signalling and blocks colorectal cancer growth

被引：47
|
作者：
He, Hong [1 ]
Nhi Huynh [1 ]
Liu, Kevin H. [1 ]
Malcontenti-Wilson, Cathy [1 ]
Zhu, Jin [2 ,3 ]
Christophi, Christopher [1 ]
Shulkes, Arthur [1 ]
Baldwin, Graham S. [1 ]
机构：
[1] Univ Melbourne, Dept Surg, Austin Hlth, Melbourne, Vic 3084, Australia
[2] Third Mil Med Univ, Southwest Hosp, Chongqing 400038, Peoples R China
[3] Third Mil Med Univ, Inst Hepatobiliary Surg, Chongqing 400038, Peoples R China
来源：
CANCER LETTERS | 2012年 / 317卷 / 01期
基金：
英国医学研究理事会;
关键词：
PAK1; beta-Catenin; CRC; P21-ACTIVATED KINASES; COLON-CANCER; MUTATIONS; RAS; APC; PROGRESSION; METASTASIS; PROTEIN; KRAS; WNT;
D O I：
10.1016/j.canlet.2011.11.014
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The p21-activated kinase 1 (PAK1) plays important roles in cell growth, motility, and transformation. The aims of this study were to delineate the signalling mechanisms downstream of PAK1, and to investigate the importance of PAK1 for colorectal cancer (CRC) growth and metastasis in vivo. PAK1 knockdown in human CRC cell lines inhibited beta-catenin expression, beta-catenin/TCF4 transcriptional activity, and the expression of c-Myc. In mouse models PAK1 knockdown suppressed the growth and metastasis of human CRC cells by decreasing proliferation and increasing apoptosis. Our findings demonstrate for the first time the crucial role of PAK1 in CRC progression in vivo. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码：65 / 71
页数：7
相关论文
共 50 条
  • [31] Tetrandrine Inhibits Wnt/β-Catenin Signaling and Suppresses Tumor Growth of Human Colorectal Cancer
    He, Bai-Cheng
    Gao, Jian-Li
    Zhang, Bing-Qiang
    Luo, Qing
    Shi, Qiong
    Kim, Stephanie H.
    Huang, Enyi
    Gao, Yanhong
    Yang, Ke
    Wagner, Eric R.
    Wang, Linyuan
    Tang, Ni
    Luo, Jinyong
    Liu, Xing
    Li, Mi
    Bi, Yang
    Shen, Jikun
    Luther, Gaurav
    Hu, Ning
    Zhou, Qixin
    Luu, Hue H.
    Haydon, Rex C.
    Zhao, Yingming
    He, Tong-Chuan
    MOLECULAR PHARMACOLOGY, 2011, 79 (02) : 211 - 219
  • [32] p21-Activated Kinase: Role in Gastrointestinal Cancer and Beyond
    Li, Xiaodong
    Li, Feng
    CANCERS, 2022, 14 (19)
  • [33] Knockdown of PFTAIRE Protein Kinase 1 (PFTK1) Inhibits Proliferation, Invasion, and EMT in Colon Cancer Cells
    Zhu, Jiankang
    Liu, Chongzhong
    Liu, Fengyue
    Wang, Yadong
    Zhu, Min
    ONCOLOGY RESEARCH, 2016, 24 (03) : 137 - 144
  • [34] A Coactivator Role of CARM1 in the Dysregulation of β-Catenin Activity in Colorectal Cancer Cell Growth and Gene Expression
    Ou, Chen-Yin
    LaBonte, Melissa J.
    Manegold, Philipp C.
    So, Alex Yick-Lun
    Ianculescu, Irina
    Gerke, Daniel S.
    Yamamoto, Keith R.
    Ladner, Robert D.
    Kahn, Michael
    Kim, Jeong Hoon
    Stallcup, Michael R.
    MOLECULAR CANCER RESEARCH, 2011, 9 (05) : 660 - 670
  • [35] P21-activated kinase 1 stimulates colon cancer cell growth and migration/invasion via ERK- and AKT-dependent pathways
    Huynh, Nhi
    Liu, Kevin H.
    Baldwin, Graham S.
    He, Hong
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2010, 1803 (09): : 1106 - 1113
  • [36] Regulation of Vascular Injury and Repair by P21-Activated Kinase 1 and P21-Activated Kinase 2: Therapeutic Potential and Challenges
    Han, Chuting
    Zhu, Mengying
    Liu, Yiting
    Yang, Yan
    Cheng, Jun
    Li, Pengyun
    BIOMOLECULES, 2024, 14 (12)
  • [37] Depletion of p21-activated kinase 1 up-regulates the immune system of APCΔ14/+ mice and inhibits intestinal tumorigenesis
    Huynh, Nhi
    Wang, Kai
    Yim, Mildred
    Dumesny, Chelsea J.
    Sandrin, Mauro S.
    Baldwin, Graham S.
    Nikfarjam, Mehrdad
    He, Hong
    BMC CANCER, 2017, 17
  • [38] Myricetin suppresses p21-activated kinase 1 in human breast cancer MCF-7 cells through downstream signaling of the β-catenin pathway
    Jia, De
    Zhang, Xue Dong
    ONCOLOGY REPORTS, 2016, 36 (01) : 342 - 348
  • [39] Solasodine inhibits human colorectal cancer cells through suppression of the AKT/glycogen synthase kinase-3/-catenin pathway
    Zhuang, Yu-wen
    Wu, Cun-en
    Zhou, Jin-yong
    Chen, Xu
    Wu, Jian
    Jiang, Shan
    Peng, Hai-yan
    Zou, Xi
    Liu, Jia-yun
    Wu, Da-peng
    Gong, Tao
    Qi, Ming-hao
    Xue, Tian
    Liu, Shen-lin
    Cai, Hui
    CANCER SCIENCE, 2017, 108 (11) : 2248 - 2264
  • [40] LincRNA-p21 Inhibits the Wnt/β-Catenin Pathway in Activated Hepatic Stellate Cells via Sponging MicroRNA-17-5p
    Yu, Fujun
    Guo, Yong
    Chen, Bicheng
    Shi, Liang
    Dong, Peihong
    Zhou, Mengtao
    Zheng, Jianjian
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2017, 41 (05) : 1970 - 1980
12345